Results 21 to 30 of about 4,240,909 (230)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection

The Scientific World Journal, 2013
Serum levels of the tumor marker CA19-9 have been reported to be elevated in patients with hepatocellular carcinoma (HCC), but its clinicopathologic significance is still unknown.
Yu-Ling Chen, Chien-Hung Chen, Rey-Heng Hu, Ming-Chih Ho, Yung-Ming Jeng   +4 more
doaj   +2 more sources

Prognostic value of pre-treatment serum CA19-9 and lymphocyte-to-monocyte ratio in HR+/HER2- breast cancer: a retrospective cohort study [PDF]

BMC Cancer
Background The prognostic significance of carbohydrate antigen 19 − 9 (CA19-9) and the lymphocyte-to-monocyte ratio (LMR) in hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2-) breast cancer remains unclear. This study
Jia Hu, Zhenchong Xiong, Xi Wang
doaj   +2 more sources

Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma [PDF]

Scientific Reports, 2021
Inflammation promotes tumor progression, induces invasion and metastatic spread. This retrospective study explored CRP, CA19-9, and routine laboratory values as preoperative prognostic factors in pancreatic cancer patients.
Anna M. Nurmi, Harri K. Mustonen, Ulf-Håkan Stenman, Hanna E. Seppänen, Caj H. Haglund   +4 more
doaj   +2 more sources

CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer [PDF]

BMC Gastroenterology
Background Pancreatic head-type autoimmune pancreatitis (PH-AIP) with elevated CA19-9 is sometimes difficult to distinguish from pancreatic head cancer (PHC) with elevated CA19-9. At times, IgG4 proves inadequate in offering assistance.
Wenfeng Xi, Wanying Liao, Tao Guo, Qingwei Jiang, Xiaoyin Bai, Xi Wu, Yunlu Feng, Shengyu Zhang, Dongsheng Wu, Qiang Wang, Aiming Yang   +10 more
doaj   +2 more sources

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma

Frontiers in Oncology, 2021
BackgroundAlthough carbohydrate antigen 19-9 (CA19-9) is an established prognostic marker for intrahepatic cholangiocarcinoma (ICC) patients, the significance of elevated preoperative CA19-9 that normalized after resection remains unknown.
Hui Li, Hui Li, Yuan Feng, Yuan Feng, Chang Liu, Jiawang Li, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li   +9 more
doaj   +1 more source

Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas

BMC Cancer, 2021
Background CA19–9 is one of the most widely used tumor markers in biliary-pancreatic diseases. The measured value may not factually reflect the genuine CA19–9 level secreted by tumor, which affected by biliary obstruction.
Bangbo Zhao, Qin Cheng, Hongtao Cao, Xingtong Zhou, Tianhao Li, Liangbo Dong, Weibin Wang   +6 more
doaj   +1 more source

Abdominal Pain and Increased CA19-9 [PDF]

Clinical Chemistry, 2013
A 32-year-old man with an unremarkable medical history presented to the ambulatory clinic with complaints of nonlocalized abdominal pain. The results of a physical examination were unremarkable. The results obtained from liver, pancreatic, and renal testing were within the reference intervals, and the results of both a fecal occult blood test and an ...
Graziani G., Cucchiari D., Podesta' M. A., Quagliuolo V., Montanelli A.   +4 more
openaire   +2 more sources

Elevated tumor markers in a benign lung disease

Journal of Cardiothoracic Surgery, 2021
Background This study aimed to determine the underlying pathophysiologic mechanism of elevated carbohydrate antigen 19-9 (CA19-9) in pulmonary sequestration (PS) patients. Materials and methods Four pulmonary sequestration patients, 12 pneumonia patients
Quan Chen, Qijue Lu, Xiang Fei, Chunguang Li, Bai Li   +4 more
doaj   +1 more source

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center

Frontiers in Oncology, 2022
BackgroundPancreatic cancer mortality is growing every year, and radical resection is the most essential therapy strategy. It is critical to evaluate the long-term prognosis of individuals receiving radical surgery.
Zuowei Wu, Pengcheng Zhao, Zihe Wang, Xing Huang, Chao Wu, Mao Li, Li Wang, Bole Tian   +7 more
doaj   +1 more source

CA19-9 as a therapeutic target in pancreatitis [PDF]

Annals of Translational Medicine, 2019
The glycan carbohydrate antigen 19-9 (CA19-9) is one of the most important and widely used biomarkers for pancreatic cancer. In 1979, Koprowski et al. first described CA 19-9 as a tumor antigen recognized by the monoclonal antibody NS19-9 (1).
Shingo, Kato, Kazufumi, Honda
openaire   +2 more sources